The smart investor is not sexy

Investing to make a profit isn't sexy; it isn't exciting, nor does it evoke emotions. We all wish to possess the philosopher's stone, the ability to turn valueless metals into gold. We're always on the lookout for the "news" that could change our lives and grant us the wealth we've always dreamt of.

Doing things that are simpler, more mundane is boring: why wait for years for compounding interest to perform its extraordinary task of multiplying when there are fast and efficient ways to achieve ever-increasing capitalization of our investments? Is it better to diversify into all the world's stocks simultaneously, relying on the world's growth over time, or is it better to chase fantasies?

The sexier your approach to investment, the worse your performance will be in a bear market. It's boring to invest our savings in a product that doesn't require constant monitoring or continuous changes, a product whose dynamics you don't need to understand every time. It's dull to imagine that you can keep that product, which fulfills most of our life's needs, in a drawer for years. Is it too simple? How boring is it to have had an increase like the one shown in the graph?

Investing in global stock markets: the average return has been 5.05% over the past 23 years and 12.35% over the last 10 years. What would this unexciting stuff have given you in terms of money in your pocket? Let's check it out by imagining an investment of $100,000:

  • From 12/29/2000 to 10/10/2023, the amount would have become approximately $310,000
  • From 10/10/2013 to 10/10/2023, the amount would have become approximately $320,000

Boring? Not very sexy? If successful investing is boring, then let it be. It's necessary: time, patience, discipline, and the ability to ignore the madness of the crowd. You can't brag about being boring to your friends and colleagues. No one writes brilliant profiles about ordinary people who diligently save and invest their hard-earned money, keep taxes to a minimum, and stay the course. Not sexy? Patience.

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

Cattle Market Forecast 2024


Mechanical osteoarthritis of the hip in a one medicine concept: a narrative review


Placebo-Controlled Trial of Daily Oral Cannabidiol as Adjunctive Treatment for Cats with Chronic Gingivostomatitis


Comparison of metrics to assess antibiotic use in small ruminants at a university referral clinic between 2005 and 2019 


Retrospective evaluation of the incidence of gastrointestinal bleeding in dogs receiving ophthalmic nonsteroidal anti-inflammatory drugs




News of interest


Copyright © 2023 - All Rights Reserved
ISSN 2768-198X